Pfizer Inc (MIL:1PFE)
€ 24.625 -0.16 (-0.65%) Market Cap: 138.78 Bil Enterprise Value: 192.52 Bil PE Ratio: 34.89 PB Ratio: 1.59 GF Score: 64/100

Pfizer Inc at JPMorgan Healthcare Conference (Virtual) - Fireside Chat Transcript

Jan 12, 2021 / 03:00PM GMT
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody, and thanks for joining us. I'm Chris Schott at JPMorgan, and I'm pleased to be hosting a fireside chat with Pfizer's Chairman and CEO, Albert Bourla, this morning. Albert, thanks for joining us.

Albert Bourla
Pfizer Inc. - Chairman & CEO

Thanks.

Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst

Yes. And maybe just to open up, there's a lot to dig into in the story between COVID and your pipeline progression, et cetera. But I think maybe you should make some opening remarks in terms of Pfizer's positioning and priorities as we think about 2021.

Albert Bourla
Pfizer Inc. - Chairman & CEO

Thank you very much, Chris. Thank you for the opportunity to talk to you. And let me also just quickly remind everyone that, of course, I will be making forward-looking statements and that actual results may be different. We always

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot